Loading company…
PharmAlliance provides drug discovery, development and commercialization services.
PharmAlliance serves emerging and established pharmaceutical, biotechnology, life sciences and medical device companies. The US-based company was founded in 2022 and formed by Waud Capital Partners in September 2023. Mark Bouck was its CEO as of 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in